Abstract b-thalassemia is the
Introduction
b-thalassemia is a recessive monogenic disorder encountered worldwide with a higher prevalence among Mediterranean, Middle Eastern and Indian populations [1] . The disease is due to mutation in b globin locus for which more than 200 alleles have been reported [2] . Carriers present mild anemia while affected patients have severe anemia and require regular transfusion. Intermedia phenotype with occasional or no transfusion might also occur in patients who inherited mild b globin mutations or in the presence of modulators. Hemoglobin disorders are highly prevalent among Iranians specially those originating from northern and southern provinces [3] [4] [5] . Northern Iranian b-thalassemia traits are genetically highly heterogeneous and more than 25 b globin gene mutations were described in this population [3, 4] .
In this report, we describe a rare hemoglobin variant caused by a mutation in b-globin gene, HBB:c.82G[T: Codon 27 GCC?TCC (Ala?Ser), Hb Knossos, which produces the classical phenotype of intermedia b-thalassemia in association with HBB:c.315
Hb Knossos was first described in a Greek family in which thalassemia intermedia was diagnosed for three members who were compound heterozygous for a typical b-thalassaemia and this variant [6] . It was demonstrated that some b Knossos RNA transcripts utilize a cryptic splice sequence and are therefore abnormally processed [7] and the amount of the variant in carriers is approximately 30 % of the total hemoglobin [8] .
In heterozygous state, the mutation results in mild bthalassemia phenotype with a normal HbA2 level, whereas the homozygous state results in intermediate b-thalassemia [9, 10] . It's slightly decreased oxygen affinity may account for the observed phenotypes [11] .
This rare variant was previously reported in North African (Egypt, Algeria, Tunisia, Lybia), Mediterranean (Greece, Turkey) and Middle Eastern (Jordan) populations. The highest frequency for this mutation was observed among Jordans with 3.3 % prevalence while a frequency less than 1 % was reported for others [12] .
To our knowledge this variant has not been previously reported among Iranians. Moreover the combination of this hemoglobin variant with HBB:c.315?1G[A (IVSII-I) b O mutation and its associated phenotype is described for the first time.
Case Report
The case is a 16 years old boy originating from north Iran, Mazandaran province, with severe microcytosis and hypochromia and elevated HbF who so far has not been transfused and is consequently considered as thalassemia intermedia. His father is 38 years old with no abnormal phenotype and borderline hematological indices. His mother is 35 years old with hematological indices typical of b-thalassemia trait (Table 1) .
Molecular analysis of previously reported b globin point mutations in this province were screened by reverse dot blot method for all three members of the family and so far only HBB:c.315?1G[A (IVSII-1) was detected in the patient and his mother. Finally, direct sequencing of amplified DNA of the b globin gene of the young boy revealed a second mutation at codon 27 of exon 1 with GCC?TCC (Fig. 1) , causing an Ala?Ser substitution in b globin chain; HBB:c.82G[T. The presence of this point mutation which leads to the synthesis of Hb Knossos variant [a 2 b 2 27(b9) Ala?Ser] was also confirmed at the DNA level in the father by a home-made reverse dot blot assay.
Molecular analysis of alpha chain was also performed and none of the alpha-globin gene deletions or point mutations commonly reported in Iran [12] were detected in this patient.
Discussion
Despite the abundance of b globin alleles in the world, most populations present a limited spectrum of these mutations and in the majority of cases five to ten different mutations cover more than 90 % of mutant alleles. In Iran, due to the high heterogeneity of the population, more than 60 different b globin gene mutations were reported and there are still new cases reported in the recent years highlighting the genetic complexity of thalassemia in this part of the world.
Hb Knossos, b27 (B9) Ala?Ser [HBB:c.82G[T] is a rare Hb variant in the world present in North Africa and Mediterranean region at a frequency lower than 1 % and with a relatively higher prevalence in Jordan (3.3 %) [13] . To our knowledge, this is the first time this mutation is reported in Iran. As Hb Knossos was also rarely reported in Turkish population [14] [15] [16] , the western neighbor of Iran, we hypothesized that this mutation might have spread over the Middle Eastern and Mediterranean countries. Our data also confirm that compound heterozygosity for Hb Knossos and a b O mutation [IVSII-1 (G-A)] does not cause severe transfusion dependent thalassemia. This is again the first time such allelic combination is reported. Other combinations with either b O codon39 (C?T) [10] , C8(-AA) [14] , [15] leading to thalassemia intermedia with different degrees of severity were reported in other parts of the world while a case of thalassemia major compound heterozygous patient harboring a b ? mutation [IVSII-745(C-G)] was also reported [16] . Taken together these phenotypic variations suggest that other genetic components might be implicated in determining the severity of anemia in compound heterozygotes.
This report provides a further piece of evidence of the high heterogeneity of b globin mutations in Iran and the hematological features of the proband which reveal the hemoglobin Knossos as a silent mutation highlight the necessity of deep molecular characterization of subjects presenting normal HbA2 level associated with abnormal or borderline red cell indices during premarital screening specially when the partner is a typical b thalassemia trait in order to reach a better genetic counseling and control of severe anemia child births.
